首页> 外文期刊>Cancer biology & therapy >Heat shock proteins as biomarkers of lung cancer
【24h】

Heat shock proteins as biomarkers of lung cancer

机译:热休克蛋白作为肺癌的生物标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Heat shock proteins are known to be associated with a wide variety of human cancers including lung cancer. Overexpression of these molecular chaperones is linked with tumor survival, metastasis and anticancer drug resistance. In recent years, heat shock proteins are gaining much importance in the field of cancer research owing to their potential to be key determinants of cell survival and apoptosis. Lung cancer is one of the most common cancers diagnosed worldwide and the association of heat shock proteins in lung cancer diagnosis, prognosis and as drug targets remains unresolved. The aim of this review is to draw the importance of heat shock protein members; Hsp27, Hsp70, Hsp90, Hsp60 and their diagnostic and prognostic implications in lung cancer. Based on the available literature heat shock proteins can serve as biomarkers and anticancer drug targets in the management of lung cancer patients.
机译:已知热休克蛋白与各种人类癌症有关,包括肺癌。 这些分子伴侣的过度表达与肿瘤存活,转移和抗癌耐药相关。 近年来,由于其潜力成为细胞存活和细胞凋亡的关键决定簇,热休克蛋白在癌症研究领域越来越重要。 肺癌是在全球诊断的最常见的癌症之一,肺癌诊断,预后和药物靶标的热休克蛋白质的结合仍未解决。 本综述的目的是提高热休克蛋白成员的重要性; HSP27,HSP70,HSP90,HSP60及其对肺癌的诊断和预后影响。 基于可用的文献热休克蛋白可以作为肺癌患者管理中的生物标志物和抗癌药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号